5. Background
Established: 1989
85% export to Americas , Asia and Europe
Production plants in Malaysia , Thailand and China
Main Product:
Clean Room and Health care gloves
Finger cots , face masks and packaging bags
6.
7. Historical Analysis
Riverstone share price (Jan 2009 – Dec 2013)
1
2
4
5
3
1. Global economy faced recession
2. Good company performance
3. Stock markets fall
4. Higher sales of healthcare gloves
5. Production capacity expanding
16. SWOT ANALYSIS
Strengths
• Established and reputable brand
• Ability and willingness to meet customers'
needs
• Strong financial position and no long term
debt
• Niche business provides a wide moat
• Enlarging capacity provides growth
opportunities and economies of scale
• Sound management
Weakness
Opportunities Threats
18. SWOT ANALYSIS
Strengths Weaknesses
Opportunities
• Demand for cleanroom gloves to stay
healthy
• Demand for healthcare gloves to grow
by European
• Tablet and mobile device manufacturing
• Customized medical gloves to provide
growth driver
Threats
19. SWOT ANALYSIS
Strengths Weaknesses
Opportunities
Threats
• Upstream price fluctuations may lead to
higher costs
• Exposure to forex volatility
• Slowdown in economy and
semiconductor related manufacturing
• Higher raw material costs
• Foreign exchange risk
28. Risk Analysis
Riverstone Supermax Kossan
Beta 0.1854 0.2776 0.1232
Average return (%) 0.2225 0.6943 0.3764
Standard deviation 0.0330 0.0669 0.0597
Riverstone is an attractive investment for risk adverse investors.
29. Risk free rate: 2.46% (Singapore Government 10-year bond yield)
Market Return: 13.56% (By analyzing the MSCI world Index past return)
Return of equity=2.46+0.1854*(13.56-2.46)=4.5179%
No debt
WACC=Return of equity
WACC
32. Why failed?
Growth rate (%) 2009 2010 2011 2012 2013
Total revenue 10.2% 42.3% 23.1% 13.6% 15.5%
Gross profit 31.5% 29.0% 22.6% 23.1% 27.3%
Net income 19.0% 18.2% 14.2% 12.8% 16.2%
DDM is limited to firms that are growing at a stable rate.
35. 4 Assumptions:
Sales to grow for the next 5 years at 23.13%
Operating expense/income - Used historical average of
percentages of sales
Capital expenditure to grow at 17% p.a.
Tax rate of 20% of EBT for the next 5 years
FCFF method
36. FCFF method
2014 2015 2016 2017 2018
Currency (in millions) MYR MYR MYR MYR MYR
Free cash flow to firm (FCFF) 4.89 25.85 34.99 46.75 61.86
Discount factor (at 4.5179% WACC) 1.0452 1.0924 1.1418 1.1934 1.2473
Present value (PV) of FCFF 4.68 23.66 30.64 39.17 49.60
Total PV of five year FCFF 147.75
Terminal value 3,079.92
PV of terminal value 2,469.27
PV of total FCFF* (in millions MYR) 2,617.02
Total PV on 8 August 2014 (MYR) 2,687,653,401.53
Number of shares 371,226,025.00
Share Price (MYR) 7.24
Share Price (in SGD)** 2.82